MIR4435-2HG |
|
MIR4435-2 host gene
|
|
|
0.604 |
0.692 |
TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
MAPT-AS1 |
|
MAPT antisense RNA 1
|
|
|
0.711 |
0.269 |
ZNRD1ASP |
|
zinc ribbon domain containing 1 antisense, pseudogene
|
|
|
0.691 |
0.538 |
LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
HCG9 |
|
HLA complex group 9
|
|
|
0.700 |
0.500 |
CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
INHCAP |
|
inhibitor of carbonic anhydrase pseudogene
|
|
|
0.890 |
0.231 |
ZMIZ1-AS1 |
|
ZMIZ1 antisense RNA 1
|
|
|
0.780 |
0.115 |
PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
CHKB-CPT1B |
|
CHKB-CPT1B readthrough (NMD candidate)
|
|
|
0.769 |
0.385 |
USP8P1 |
|
USP8 pseudogene 1
|
|
|
0.805 |
0.269 |
LINC01221 |
|
long intergenic non-protein coding RNA 1221
|
|
|
1.000 |
0.038 |
LINC02210 |
|
long intergenic non-protein coding RNA 2210
|
|
|
0.861 |
0.154 |
LINC00649 |
|
long intergenic non-protein coding RNA 649
|
|
|
0.931 |
0.115 |
LINC02356 |
|
long intergenic non-protein coding RNA 2356
|
|
|
0.931 |
0.115 |
TMEM72-AS1 |
|
TMEM72 antisense RNA 1
|
|
|
|
|
KANSL1-AS1 |
|
KANSL1 antisense RNA 1
|
|
|
0.839 |
0.154 |
H2AC5P |
|
H2A clustered histone 5, pseudogene
|
|
|
0.931 |
0.115 |
HLA-J |
|
major histocompatibility complex, class I, J (pseudogene)
|
|
|
0.861 |
0.269 |
LINC02829 |
|
long intergenic non-protein coding RNA 2829
|
|
|
0.890 |
0.231 |
H2AC9P |
|
H2A clustered histone 9, pseudogene
|
|
|
1.000 |
0.038 |
H2BP5 |
|
H2B histone pseudogene 5
|
|
|
0.890 |
0.154 |
H2AC10P |
|
H2A clustered histone 10, pseudogene
|
|
|
1.000 |
0.038 |
FAM21FP |
|
family with sequence similarity 21 member F, pseudogene
|
|
|
|
|